Corient Private Wealth’s Parabilis Medicines PBLS Stock Holding History
Bought
Maintained
Sold
Other funds holding PBLS
SL
Corient Private Wealth's PBLS Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Parabilis Medicines (PBLS) in Q3 2026: 37,792 shares worth $1.22M. The stake represents ﹤0.01% of the portfolio and ranks #1923 among its holdings.
127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.
- Corient Private Wealth held 37,792 shares of Parabilis Medicines worth $1.22M as of Q3 2026.
- Parabilis Medicines was a new Corient Private Wealth position in Q3 2026.
- Parabilis Medicines made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #1923 holding.
- 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.